west china medical publishers
Keyword
  • Title
  • Author
  • Keyword
  • Abstract
Advance search
Advance search

Search

find Keyword "毒副作用" 2 results
  • Observation and Analysis of Toxic and Side Effect of Continuous Hyperthermic Peritoneal Perfusion Chemotherapy

    Objective To observe the toxic and side effects during the continuous hyperthermic peritoneal perfusion chemotherapy (CHPPC).Methods Abdominal paracentesis and catheterization were performed under ultrasound guidance, then CHPPC was carried out, which was in temperature of 42-44 ℃ for 1 h. The changes of body temperature, heart rate, blood pressure, saturation of blood oxygen and respiratory frequency were recorded in 109 patients during and after perfusion, meanwhile symptoms and physical signs of abdominal region and system status such as abdominal tenderness, rebound tenderness were observed. Results There were no significant differences of body temperature, heart rate, blood pressure, saturation of blood oxygen or respiratory frequency between before and after perfusion (Pgt;0.05). There were 25 patients with abdominal pain, but in which only 3 patients with symptoms of acute abdomen, 26 patients with gastrointestinal symptoms, 20 patients with myelosuppression, and others (22 cases) with aches of puncture position which were released by symptomatic treatment. Conclusion There are less toxic and side effect and better tolerance in patients with CHPPC application 1 month after operation.

    Release date:2016-09-08 04:26 Export PDF Favorites Scan
  • 替吉奥联合奥沙利铂治疗晚期结直肠癌的临床观察

    目的评价替吉奥胶囊联合奥沙利铂治疗晚期结直肠癌患者的近期疗效和不良反应。 方法回顾性分析2010年8月-2012年12月64例晚期结直肠癌患者资料,32例采用替吉奥联合奥沙利铂(L-OHP)方案化学疗法(替吉奥组),32例采用氟尿嘧啶联合奥沙利铂(FOLFOX)方案化学疗法(氟尿嘧啶组),2周期后评价两组疗效及不良反应。 结果替吉奥组和氟尿嘧啶组总有效率分别为50.0%和46.9%,两组差异无统计学意义(χ2=0.063,P=0.802);两组骨髓抑制及胃肠道反应发生率相近,但静脉炎的发生率替吉奥组明显低于氟尿嘧啶组(0.0%、9.4%,P<0.05)。 结论替吉奥胶囊联合奥沙利铂治疗晚期结直肠癌,近期疗效较好,不良反应较轻。

    Release date: Export PDF Favorites Scan
1 pages Previous 1 Next

Format

Content